Corvex, Inc. (MOVE) is projected to report Q3 2026 revenue of $5.54 million and an EPS loss of $0.09, with the current stock price of $5.04 trailing the average analyst price target of $18.75.
Investors are primarily focused on the company’s ability to convert its $22 million in Q2 2026 contracted annualized recurring revenue (ARR) into recognized GAAP revenue. This report serves as a critical test of management’s execution following the company’s pivot from healthcare technology to AI cloud computing via its March 2026 merger.
Key watch items include progress on the recently announced 5x data center capacity expansion and the operational status of the security-first Token Factory inference platform.